|
Arthur Levinson became chairman and chief executive officer of Genentech in July 1995. Levinson was appointed a member of the board of directors that same year and was named chairman of the board in 1999.
Levinson joined the company in 1980 as a senior scientist and subsequently held the position of staff scientist and director of Cell Genetics at Genentech. He became vice president of Research Technology in 1989, vice president of Research in 1990, senior vice president of Research in 1992, and senior vice president of Research and Development in 1993. He has been a member of Genentech's executive committee since 1990. Prior to his employment with Genentech, Levinson was a postdoctoral fellow in the department of microbiology at the University of California, San Francisco.
During his career, Levinson has served on the editorial boards of Molecular Biology and Medicine, Molecular and Cellular Biology, The Journal of Virology, and Virology. He also served on the boards of the Pharmaceutical Research and Manufacturers of America, the Biotechnology Industry Organization, and the California Healthcare Institute. Levinson has authored or co-authored more than 80 scientific articles and has been a named inventor on 11 United States patents, including inventions in the research of production of recombinant proteins.
Levinson is a member of the American Society of Microbiology and the American Society for Biochemistry and Molecular Biology. Levinson sits on the board of scientific consultants for the Memorial Sloan-Kettering Cancer Center and is a member of the advisory councils for the California Institute for Quantitative Biomedical Research (QB3), the Princeton University Department of Molecular Biology, and the Lewis-Sigler Institute for Integrative Genomics, also at Princeton. He also serves on the board of the Technology Network. | 